Pro-ficiency Acquires Fugitive Labs

July 12, 2022

Pro-ficiency has acquired all life-sciences intellectual property and the associated team of Fugitive Labs, bringing Fugitive's product development capabilities and team (led by Erik Guffrey) into Pro-ficiency's platform. The deal expands Pro-ficiency's product development capacity for clinical-trials simulation and performance-management products and is the company's first acquisition since being funded by NovaQuest Private Equity in 2021.

Buyers
Pro-ficiency
Targets
Fugitive Labs
Platforms
Pro-ficiency
Location
North Carolina, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.